Tag

vaccines — 1 page

Closed mFlusiva Approval — First mRNA Flu Vaccine Cleared by the FDA The FDA approved Moderna's mFlusiva on Aug 5, 2026 — the first mRNA seasonal flu vaccine — for adults 50 and older, after trials showed about 27% better protection than standard flu shots. Science · Aug 23